Prolonged viral replication in patients with hematologic malignancies hospitalized with COVID-19

Funding: This work has been financed by funds for research ad hoc COVID-19 from citizens and organizations patronage to Hospital Clínic de Barcelona-Fundació Clínic per a la Recerca Biomèdica. This research forms part of an activity that has received funding from EIT Health. EIT Health is supported by the European Institute of Innovation and Technology (EIT), a body of the European Union that receives support from the European Union´s Horizon 2020 Research and Innovation Program. PP-A [JR20/00012 and PI21/00498], NG-P [FI19/00133], and CG-V [PI21/01640] have received research grants funded by Instituto de Salud Carlos III (ISCIII) and co-funded by the European Union. The funders had neither a specific role in study design or collection of data, nor in writing of the paper or decision to submit.